Seres Therapeutics (MCRB) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Seres Therapeutics (MCRB) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Seres Therapeutics

· MCRB

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

34.596 M

-3.74%

General

Market Cap: $34.6M
Enterprise Value: $73.49M
Shares Outstanding: 9,680,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 82.58%
Operating Margin: -4462.77%
Net Profit Margin: -1192.94%
FCF Margin: -2724.11%
ROA: -22.11%
ROE: -60.32%
ROIC: -89.99%
Current Ratio: 2.11
Debt-to-Equity: 1.64
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 17.23
P/FCF: —
P/B: 0.94
EV/EBITDA: -1.66

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 1648.67%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): -52.67%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: -649.09%
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $1.88M
Gross Margin: 82.58%
Operating Expenses: $85.59M
Operating Income: -$84.03M
Net Profit: -$22.46M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $15.59M
Working Capital: $22.32M
Total Assets: $101.59M
Net Debt: $41.05M
Total Liabilities: $67.05M
Total Equity: $34.53M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$51.26M
Cash Flow from Investing: $187K
Cash Flow from Financing: $14.86M
Free Cash Flow: -$51.3M
Capital Expenditures: $37K